Deborah Quinn
2015
In 2015, Deborah Quinn earned a total compensation of $550.4K as Chief Medical Officer at Bellerophon Therapeutics.
Compensation breakdown
| Bonus | $195,000 |
|---|---|
| Option Awards | $68,414 |
| Salary | $271,154 |
| Stock Awards | $5,476 |
| Other | $10,361 |
| Total | $550,405 |
Quinn received $271.2K in salary, accounting for 49% of the total pay in 2015.
Quinn also received $195K in bonus, $68.4K in option awards, $5.5K in stock awards and $10.4K in other compensation.
Rankings
In 2015, Deborah Quinn's compensation ranked 10,455th out of 13,638 executives tracked by ExecPay. In other words, Quinn earned more than 23.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,455 out of 13,638 | 23rd |
Division Manufacturing | 3,989 out of 5,190 | 23rd |
Major group Chemicals And Allied Products | 1,468 out of 1,854 | 21st |
Industry group Drugs | 1,208 out of 1,528 | 21st |
Industry Pharmaceutical Preparations | 944 out of 1,182 | 20th |
Source: SEC filing on March 20, 2017.
Quinn's colleagues
We found five more compensation records of executives who worked with Deborah Quinn at Bellerophon Therapeutics in 2015.
2015
Jonathan Peacock
Bellerophon Therapeutics
Chief Executive Officer
2015
Martin Meglasson
Bellerophon Therapeutics
Chief Scientific Officer
2015
Reinilde Heyrman
Bellerophon Therapeutics
former Chief Clinical Development Officer
2015
Martin Dekker
Bellerophon Therapeutics
Vice President of Device Engineering and Manufacturing
2015
Peter Fernandes
Bellerophon Therapeutics